epirubicin has been researched along with Hyperplasia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, Z; Dang, Y; Fei, F; Li, Q; Liu, L; Liu, X; Sun, S; Wang, J; Wang, X; Wang, Y; Wu, J; Yao, Y; Yu, M; Zhang, R | 1 |
| Ala, U; Brusa, D; Calautti, E; Magnuson, MA; Neri, F; Oliviero, S; Provero, P; Riganti, C; Saoncella, S; Tassone, B | 1 |
| Göğüş, O; Ozdiler, E; Sözen, S; Yaman, O | 1 |
3 other study(ies) available for epirubicin and Hyperplasia
| Article | Year |
|---|---|
Screening in larval zebrafish reveals tissue-specific distribution of fifteen fluorescent compounds.
Topics: Animals; Anthraquinones; Bone and Bones; Bone Density; Doxorubicin; Epirubicin; Fluorescent Dyes; Hyperplasia; Larva; Mice, Inbred C57BL; Oncogenes; Organ Size; Organ Specificity; Tissue Distribution; Zebrafish | 2017 |
Rictor/mTORC2 deficiency enhances keratinocyte stress tolerance via mitohormesis.
Topics: Acetylcysteine; Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Cellular Senescence; Epirubicin; Glutamic Acid; Hyperplasia; Keratin-14; Keratinocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Radiation Tolerance; Rapamycin-Insensitive Companion of mTOR Protein; Reactive Oxygen Species; Skin; Tetradecanoylphorbol Acetate; Transcriptome; X-Rays | 2017 |
Transmurally absorbed intravesical chemotherapy with dimethylsulfoxide in an animal model.
Topics: Administration, Intravesical; Animals; Antibiotics, Antineoplastic; Carcinogens; Dimethyl Sulfoxide; Disease Models, Animal; Epirubicin; Excipients; Hyperplasia; Male; Methylnitrosourea; Mucous Membrane; Rats; Rats, Wistar; Urinary Bladder; Urinary Bladder Neoplasms | 1999 |